Tickers

1. Composite Trajectory Verdict

The cash flow statement matters most for assessing ADMT's financial performance given its recurring losses, auditor's going concern qualification, and reliance on a nearly maxed-out line of credit to fund operations.

Composite Trajectory: Deteriorating

Overall Assessment: The company's annual revenue grew 4.7% to $3.347M in FY2026 from $3.197M in FY2025, but the operating loss widened to -$159,097 from -$94,024, and operating cash flow swung from +$9,978 to -$124,059 (10-K 2026-03-31, Statements of Operations and Cash Flows). Cash and cash equivalents have declined sequentially from $382,969 at March 31, 2025 to $255,730 at March 31, 2026 to $222,619 at June 30, 2026 (10-K 2026-03-31, Balance Sheet; 10-Q 2026-06-30, Balance Sheet). The auditor's report identifies substantial doubt about the company's ability to continue as a going concern due to losses from operations and negative cash flows (10-K 2026-03-31, Auditor's Report). While quarterly revenue showed year-over-year growth in Q2 and Q3 FY2026, the most recent quarter (Q1 FY2027) saw an 11.0% revenue decline and a swing to operating loss (10-Q 2026-06-30, MD&A). The balance sheet shows persistent negative working capital (current liabilities exceeding current assets) and an accumulated deficit of $33.0M against equity of $571k (10-K 2026-03-31, Balance Sheet). These factors collectively indicate a deteriorating trajectory.

2. Red Flags

• Auditor's going concern qualification: "The Company has experienced losses from operations and negative cash flows from operating activities, these factors raise substantial doubt about its ability to continue as a going concern" (10-K 2026-03-31, Auditor's Report).
• Operating cash flow reversal: FY2026 net cash used in operating activities was -$124,059 versus +$9,978 in FY2025 (10-K 2026-03-31, Statements of Cash Flows).
• Cash depletion: Cash and cash equivalents fell 33% from $382,969 (March 31, 2025) to $255,730 (March 31, 2026) and a further 13% to $222,619 (June 30, 2026) (10-K 2026-03-31, Balance Sheet; 10-Q 2026-06-30, Balance Sheet).
• Negative working capital: Current liabilities ($1.046M) exceeded current assets ($1.022M) at March 31, 2026, and current liabilities ($1.235M) exceeded current assets ($1.185M) at June 30, 2026 (10-K 2026-03-31, Balance Sheet; 10-Q 2026-06-30, Balance Sheet).
• High customer concentration: Two customers accounted for 44-47% of net revenue in each quarter of FY2026 and Q1 FY2027 (10-Q 2026-06-30, MD&A; 10-Q 2025-12-31, MD&A; 10-Q 2025-09-30, MD&A).
• Line of credit near limit: $379,446 drawn against ~$400,000 limit with only ~$21,000 available as of March 31, 2026 (10-K 2026-03-31, MD&A; 10-K 2026-03-31, Balance Sheet).
• Investment valuation departure from GAAP: Auditor notes investments not stated at fair value as required by GAAP, with unquantified effects (10-K 2026-03-31, Auditor's Report).
• Recurring inventory write-offs: $108,744 in FY2025, $17,012 in FY2026, $14,905 in six months ended Sept 2025, $17,012 in nine months ended Dec 2025, $797 in Q1 FY2027 (10-K 2026-03-31, Statements of Cash Flows; 10-Q 2025-09-30, Statements of Cash Flows; 10-Q 2025-12-31, Statements of Cash Flows; 10-Q 2026-06-30, Statements of Cash Flows).
• Net income volatility driven by unrealized investment gains/losses: FY2026 included $89,250 unrealized gain; Q1 FY2026 included $225,750 gain; Q1 FY2027 included $60,000 gain; Q2 FY2026 included -$111,000 loss; Q3 FY2026 included -$25,500 loss (10-K 2026-03-31, Statements of Operations; 10-Q 2026-06-30, Statements of Operations; 10-Q 2025-09-30, Statements of Operations; 10-Q 2025-12-31, Statements of Operations).
• Accumulated deficit of $33.07M dwarfs total stockholders' equity of $570,972 (10-K 2026-03-31, Balance Sheet).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Annual revenue increased 4.7% to $3.347M in FY2026 from $3.197M in FY2025, driven by electronics segment growth (+$311,916) partially offset by engineering decline (-$234,820) (10-K 2026-03-31, MD&A). However, gross profit declined 2.9% to $1.355M due to higher material costs, and the operating loss widened to -$159,097 from -$94,024 (10-K 2026-03-31, Statements of Operations). Quarterly trends are divergent: Q2 FY2026 and Q3 FY2026 showed year-over-year revenue growth of 5.6% and 7.1% respectively, but Q1 FY2027 revenue fell 11.0% to $866,255 (10-Q 2025-09-30, MD&A; 10-Q 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A). Gross margin compressed across all segments in Q1 FY2027 (46% vs 49%), while Q3 FY2026 gross margin improved slightly (34% vs 36% for the quarter). Operating expenses decreased in Q2 and Q3 FY2026 but increased 11.7% in Q1 FY2027. Net income is heavily distorted by volatile unrealized investment gains/losses, ranging from a $225,750 gain in Q1 FY2026 to a $111,000 loss in Q2 FY2026 (10-Q 2026-06-30, Statements of Operations; 10-Q 2025-09-30, Statements of Operations). The core operating loss persists across all periods.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Full-year operating cash flow deteriorated sharply, from +$9,978 in FY2025 to -$124,059 in FY2026 (10-K 2026-03-31, Statements of Cash Flows). The decline was driven by a larger net loss, a $219,545 decrease in net operating liabilities, and $106,872 in lease payments, partially offset by a $136,237 inventory reduction (10-K 2026-03-31, MD&A). Quarterly operating cash flow remains negative: -$32,959 in Q1 FY2027 vs -$14,800 in Q1 FY2026; -$63,282 for six months ended Sept 2025 vs -$437,911 in prior year; -$82,815 for nine months ended Dec 2025 vs -$510,933 in prior year (10-Q 2026-06-30, Statements of Cash Flows; 10-Q 2025-09-30, Statements of Cash Flows; 10-Q 2025-12-31, Statements of Cash Flows). While the cumulative nine-month and six-month figures improved year-over-year in FY2026, the full-year result and the most recent quarter show worsening cash consumption. No investing cash outflows occurred in FY2026 or recent quarters. Financing activities provided minimal net cash (-$3,180 in FY2026, -$152 in Q1 FY2027), with line of credit repayments nearly matching proceeds (10-K 2026-03-31, Statements of Cash Flows; 10-Q 2026-06-30, Statements of Cash Flows). Cash reserves have fallen consecutively each quarter.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Overall Assessment: Total assets declined 14.2% from $2.128M to $1.827M between March 31, 2025 and March 31, 2026, and further shifted in composition by June 30, 2026 (10-K 2026-03-31, Balance Sheet; 10-Q 2026-06-30, Balance Sheet). Cash dropped 41.7% over 15 months from $382,969 to $222,619. Accounts receivable increased 17.1% to $604,061 at June 30, 2026 from $515,660 at March 31, 2026, while inventories rose 38.5% to $347,071 from $250,624 (10-Q 2026-06-30, Balance Sheet). Accounts payable surged 87.2% to $470,008 from $251,089 over the same period, and bank overdraft decreased 48.0% to $69,558 from $133,885 (10-Q 2026-06-30, Balance Sheet). The line of credit balance remained stable near $379,000, with only ~$21,000 availability (10-K 2026-03-31, MD&A). Total liabilities fell 13.8% annually but current liabilities exceed current assets in both periods (negative working capital of -$24,300 at March 31, 2026 and -$50,000 at June 30, 2026). Stockholders' equity improved slightly to $603,336 at June 30, 2026 from $570,972 at March 31, 2026 due to Q1 net income of $32,364, but remains a fraction of the $33.0M accumulated deficit (10-K 2026-03-31, Balance Sheet; 10-Q 2026-06-30, Balance Sheet). The operating lease right-of-use asset and liability are declining as lease payments are made.

6. Data Gaps

• Q1 FY2025 (three months ended June 30, 2024) income statement and cash flow details: the 10-Q for period 2025-06-30 is truncated, preventing YoY comparison for the first quarter of FY2026.
• Q4 FY2026 (three months ended March 31, 2026) standalone quarterly results: not separately reported; only full-year FY2026 and nine-month FY2026 are available.
• Segment-level operating expense breakdown for annual periods: only total operating expenses provided in 10-K.
• Detailed composition of "Other income (expense)" for annual periods: only net totals shown.
• Terms and maturity of the line of credit: interest rate, maturity date, and covenants not disclosed in provided excerpts.
• Details of the investment portfolio causing GAAP departure: nature, fair value, and reason for non-compliance not fully described.
• Operating lease terms: remaining lease term, discount rate, and future payment schedule beyond current/noncurrent split.
• Customer concentration specifics: identities and contract terms of the two major customers representing 44-47% of revenue.
• Inventory aging and obsolescence reserves methodology: only write-off amounts disclosed, not the reserve balance or policy details.
• Allowance for credit losses: static at $975,597 across all periods; no disclosure of aging or write-off activity against the allowance.